Zusammenfassung
Die intrauterine menschliche Entwicklung durchläuft Stadien unterschiedlicher Empfindlichkeit gegenüber äußeren Einflüssen. Während sich die Reaktion auf exogene Noxen in den ersten beiden Wochen nach Konzeption weitgehend auf die Alternativen „vollständige Regeneration“ oder „Abort“ („Alles-oderNichts-Gesetz“) beschränkt, können Einflüsse in Woche 3–8 nach Konzeption zu Störungen der Organogenese und damit zu schweren morphologischen und funktionellen angeborenen Anomalien führen.
Schädigende äußere Einflüsse in der Fetalperiode ab Entwicklungswoche 9 resultieren eher in Wachstums- und Funktionsstörungen.
Nach der Thalidomid-Katastrophe zwischen 1958 und 1961 mit ca. 10.000 betroffenen Kindern (u. a. mit oft schweren Gliedmaßendefekten), gibt es bei der pharmazeutischen Industrie, Ärzten und Patientinnen Vorbehalte gegenüber dem Einsatz von Arzneimitteln in der Schwangerschaft. Ein therapeutischer Nihilismus bei chronisch kranken Schwangeren kann jedoch sowohl zu einer dramatischen Verschlechterung der Grunderkrankung der Schwangeren als auch zu einer erheblichen direkten und indirekten Gefährdung der fetalen Entwicklung führen.
Literatur
ACOG Committee on Obstetric Practice. Committee Opinion No. 637 (2015) Marijuana use during pregnancy and lactation. Obstet Gynecol 126(1):234–238
ACOG Committee Opinion No. 723 (2017) Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 130:e210–e216
Antiretroviral Pregnancy Registry Steering Committee (2018) Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 July 2018. Registry Coordinating Center, Wilmington
Areia AL, Mota-Pinto A (2022) Experience with direct oral anticoagulants in pregnancy – a systematic review. J Perinat Med 50(4):457–461
AWMF-Leitlinie Nr. 015/018: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen, AWMF-Register, Stand: 05/2019
AWMF-Leitlinie Nr. 059/005: S2k-Leitlinie „Infektionen mit Chlamydia trachomatis“. AWMF-Register, Stand 08/2016
Beex-Oosterhuis MM, Van Gool AR, Heerdink ER, van Kesteren C, van Marum RJ (2021) Clozapine treatment during pregnancy and the postpartum period: a systematic literature review. J Clin Psychiatry 83:21r13952
Bhagat M, Singh P, Sunkara SM, Abraham MT, Barroso Alverde MJ, Mundla SR, Mizrahi Drijanski A, Jobilal A, Lakkimsetti M, Nair N, Razzaq W, Abdin ZU, Gupta I (2023) Effects of methimazole vs propylthiouracil in newborns: a comparative review. Cureus 15(7):e41505
Blotiere PO, Miranda S, Weill A et al (2020) Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study. BMJ Open 10(6):e034829
Briggs GG, Freeman RK, Tower CV et al (2021) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 12. Aufl. Lippincott Williams & Wilkins, Philadelphia
Cao X, Sun M, Yang Q, Wang Q, Hou L, Wang J, Wu Y, Ge L (2022) Risk of abnormal pregnancy outcomes after using ondansetron during pregnancy: a systematic review and meta-analysis. Front Pharmacol 2(13):951072
Chatzakis C, Shahar-Nissan K, Faure-Bardon V, Picone O, Hadar E, Amir J, Egloff C, Vivanti A, Sotiriadis A, Leruez-Ville M, Ville Y (2023) The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis. Am J Obstet Gynecol S0002-9378(23):00470-2
De Felice KM, Kane S (2021) Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol 148(3):661–667
De Santis M, Di Gianantonio E, Cesari E, Ambrosini G, Straface G, Clementi M (2009) First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf 32:239–244
Degenhardt KH (1971) Pränatale Pathologie: Definition, Häufigkeit, Ätiologie und Pathogenese von Mißbildungen. In: Opitz H (Hrsg) Handbuch der Kinderheilkunde, Bd I/1. Springer, Berlin/Heidelberg/New York, S 602–624
DFG – Deutsche Forschungsgemeinschaft (2022) Maximale Arbeitsplatzkonzentrationen und biologische Arbeitsstofftoleranzwerte. https://series.publisso.de/sites/default/files/documents/series/mak/lmbv/Vol2022/Iss1/Doc001/mbwl_2022_deu.pdf. Zugegriffen am 31.05.2023
Dos Santos JF, de Melo Bastos Cavalcante C, Barbosa FT, DLG G, Duzzioni M, Tilelli CQ, Shetty AK, de Castro OW (2018) Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet 298(3):487–503
Driel D van, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS (2002) Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 66:127–140
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH (2018) Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med 16(1):205
Graham JM (2020) Update on the gestational effects of maternal hyperthermia. Birth Defects Res 112(12):943–952
Hammad I, Porter TF (2020) An update on biologic agents during pregnancy. Clin Perinatol 47(4):733–742
Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C (2013) Teratogenicity of mycophenolate confirmed in a prospective study of the European network of teratology information services. Am J Med Genet A 158:588–596
Hüttel E, Padberg S, Meister R, Beck E, Schaefer C (2017) Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment. Thromb Haemost 117(5):870–879
Huybrechts KF, Hernandez-Diaz S, Patorno E et al (2016) Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry 73:938–946
Huybrechts KF, Bateman BT, Zhu Y, Straub L, Mogun H, Kim SC, Desai RJ, Hernandez-Diaz S (2021) Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol 224(3):290.e1–290.e22
Hyoun SC, Obican SG, Scialli AR (2012) Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol 94:187–207
Kautzky A, Slamanig R, Unger A, Höflich A (2022) Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis. Acta Psychiatr Scand 145(1):6–28
Knörr K, Knörr-Gärtner H, Beller FK, Lauritzen C (1989) Geburtshilfe und Gynäkologie. Physiologie und Pathologie der Reproduktion, 3. Aufl. Springer, Berlin/Heidelberg/New York
Kunkler C, Lewis AJ, Almeida R (2022) Methamphetamine exposure during pregnancy: A meta-analysis of child developmental outcomes. Neurosci Biobehav Rev 138:104714
Lange S, Probst C, Gmel G et al (2017) Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA Pediatr 171(10):948–956
Lassen D, Ennis ZN, Damkier P (2016) First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol 118(1):32–36
Li Y, Meador KJ (2022) Epilepsy and pregnancy. Continuum (Minneap Minn) 28(1):34–54
Madisch A, Koop H, Miehlke S et al. (2023) S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). AWMF Register Nr. 021–013 vom März 2023
Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I (2019) Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Am J Obstet Gynecol 220(1):57.e1–57.e13
Merlob P, Stahl B, Klinger G (2009) Tetrada of the possible mycophenolate mofetil embryopathy: a review. Reprod Toxicol 28:105–158
Mølgaard-Nielsen D, Pasternak B, Hviid A (2013) Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med 369:830–839
Nahum GG, Uhl K, Kennedy DL (2006) Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 107:1120–1138
Oren D, Nulman I, Makhija M, Ito S, Koren G (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 50:1083–1085
Ornoy A, Weinstein-Fudim L, Ergaz Z (2017) Antidepressants, antipsychotics, and mood stabilizers in pregnancy: what do we know and how should we treat pregnant women with depression. Birth Defects Res 109(12):933–956
Osborne S, Biaggi A, Hazelgrove K et al (2022) Increased maternal inflammation and poorer infant neurobehavioural competencies in women with a history of major depressive disorder from the psychiatry research and motherhood-Depression (PRAM-D) study. Brain Behav Immun 99:223–230
Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I (2017) Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs 31(6):439–450
Patorno E, Bateman BT, Huybrechts KF, MacDonald SC, Cohen JM, Desai RJ, Panchaud A, Mogun H, Pennell PB, Hernandez-Diaz S (2017) Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology 88(21):2020–2025
Patorno E, Hernandez-Diaz S, Huybrechts KF et al (2020) Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med 17(9):e1003322
Paulus WE, Lauritzen C (2023) Medikamente und Schadstoffe in Schwangerschaft und Stillzeit. 40. Aktualisierung. Spitta, Balingen
Paulzen M, Schoretsanitis G (2023) Psychopharmakotherapie in Schwangerschaft und Stillzeit – Teil I: Schwerpunkt Schwangerschaft: Möglichkeiten der Unterstützung durch therapeutisches Drug-Monitoring. Nervenarzt 94:786–798
Ricci C, Albanese CM, Pablo LA, Li J, Fatima M, Barrett K, Levis B, Brown HK (2023) In utero acetaminophen exposure and child neurodevelopmental outcomes: systematic review and meta-analysis. Paediatr Perinat Epidemiol 37(5):473–484
Rösch C, Steinbicker V (2003) Aetiology of congenital malformations – analysis of malformation registry data compared with the Kalter & Warkany study. Reprod Toxicol 17:503–504
Silva Dal Pizzol T da, Knop FP, Mengue SS (2006) Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol 22:666–671
Steinhausen HC, Willms J, Spohr HL (1995) Die Berliner Verlaufsstudie von Kindern mit einem Fetalen Alkoholsyndrom (FAS). 2. Psychiatrische und psychologische Befunde. Monatsschr Kinderheilkd 143:157–164
Streissguth AP, Barr HM, Sampson PD (1990) Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 14:662–669
Streissguth AP, Aase JM, Clarren SK, Randels SP, La Due RA, Smith DF (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265:1961–1967
Suarez EA, Bateman BT, Hernández-Díaz S et al (2022) Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children. JAMA Intern Med 182:1149–1160
Vauzelle C, Beghin D, Cournot MP, Elefant E (2013) Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study. Reprod Toxicol 36:98–103
Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C (2017) Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 15(1):95
Wang X, Zhang T, Ekheden I, Chang Z, Hellner C, Hasselström J, Jayaram-Lindström N, D’Onofrio MB, Larsson H, Mataix-Cols D, Sidorchuk A (2022) Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: a systematic review. Neurosci Biobehav Rev 137:10464
Wang Z, Chan AYL, Coghill D, Ip P, Lau WCY, Simonoff E, Brauer R, Wei L, Wong ICK, Man KKC (2021) Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age. JAMA Intern Med 181:1332–1340
Weber-Schoendorfer C, Kayser A, Tissen-Diabate T, Winterfeld U, Eleftheriou G, Te Winkel B, Diav-Citrin O et al (2020) Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study. J Hypertens 38:133–141
Weston J, Bromley R, Jackson CF et al (2016) Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 11(11):CD010224
Wilson JD (1977) Embryotoxicity of drugs to man. In: Wilson JD, Frazer FC (Hrsg) Handbook of teratology. Plenum, New York, S 309–355
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Paulus, W.E., Juch, H. (2024). Embryologie und Teratologie. In: von Kaisenberg, C., Klaritsch, P., Hösli-Krais, I. (eds) Die Geburtshilfe. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44369-9_6-2
Download citation
DOI: https://doi.org/10.1007/978-3-662-44369-9_6-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44369-9
Online ISBN: 978-3-662-44369-9
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Embryologie und Teratologie- Published:
- 15 February 2024
DOI: https://doi.org/10.1007/978-3-662-44369-9_6-2
-
Original
Embryologie und Teratologie- Published:
- 18 March 2015
DOI: https://doi.org/10.1007/978-3-662-44369-9_6-1